Compare Campbell Soup Co. (CPB) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Campbell Soup Co. vs 22nd Century Group Inc — how do they compare? Campbell Soup Co. trades at $19.2 (market cap $5.78B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Campbell Soup Co. is far larger — about 9297.5× 22nd Century Group Inc's market cap, and Campbell Soup Co. pays a 5.16% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Campbell Soup Co. for 98 Days and 22nd Century Group Inc for 32 Days on average.
| CPB | XXII | |
|---|---|---|
Market Cap | $5.78B | $621.67K |
Volume | 11,705,427 | 45,625 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $31.66 | $483.00 |
52-Week Low | $18.90 | $0.80 |
Typical Hold Time | 98 Days | 32 Days |
Enterprise Value | $12.83B | -$3.69M |
Dividend Yield | 5.16% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Campbell's stock trades at $19.21, up 1.64% today, as the company navigates a challenging period marked by a recent 36% dividend cut and Q4 earnings miss. Technical indicators show bearish momentum with the stock trading near key support at $19, while fundamentals reveal mixed performance with revenue growth to $10.25B but declining net margins to 4.14%. The company has initiated a $500 million cost savings program and workforce reduction to address profitability concerns.
The outlook remains cautious with analyst consensus leaning heavily toward Hold (58.62%) amid execution risks of the turnaround plan. While the current P/E of 14.79 offers reasonable valuation, investors face headwinds from margin compression and competitive pressures in the packaged foods sector. The stock presents a value opportunity for patient investors but requires careful monitoring of cost-saving initiatives and sales stabilization.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Campbell Soup Co.
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
